One 'oversold' ASX 200 healthcare share to buy today

After some big share price falls, is this ASX 200 healthcare stock trading for a bargain?

| More on:
Smiling couple looking at a phone at a bargain opportunity.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) healthcare share Ramsay Health Care Ltd (ASX: RHC) is in the green today following two trading days of heavy selling.

In afternoon trade on Tuesday, the Ramsay share price is up 0.5% at $40.58 a share.

That will come as welcome news to shareholders after the ASX 200 healthcare share closed down a precipitous 6.8% on Friday following the release of its full-year results.

That decline, however, looks to reinforce Shaw and Partners' Jed Richards' buy recommendation for Ramsay Health Care (courtesy of The Bull).

Why Ramsay shares could be bargain-priced

"Ramsay is Australia's biggest private hospital operator. It also operates in the UK and Europe," Richards explains.

He noted that the ASX 200 healthcare share had tumbled from $56.47 on 6 March to trade for $44.42 a share on 29 August. And shares have since declined to the current $40.58.

According to Richards:

In our view, the shares have been oversold. The company had a market capitalisation of more than $10 billion on 29 August. The company is well managed, and we expect RHC to improve in fiscal year 2025.

What's been happening with the ASX 200 healthcare share?

As mentioned up top, Ramsay reported its FY 2024 financial results on Friday, 30 August.

And those results revealed a difficult year for the private hospital operator.

While total revenue increased 9.4% year on year to $16.77 billion, earnings before interest and tax (EBIT from continuing operations) went the other direction, falling 0.4% to $998 million.

And feeling the impacts of cost inflation, the ASX 200 healthcare share reported a 2.6% decline in profit after tax from continuing operations, which came in at $271 million.

Despite the dip in profits, management pleased passive income investors with a final dividend of 40 cents per share, fully franked. That's up 60% from the prior final dividend. And it brings the full-year passive income payout to 80 cents per share.

This sees Ramsay shares trading on a fully franked dividend yield of 2.0%. And if you're looking to bag that final dividend, you'd best hurry. Ramsay shares trade ex-dividend tomorrow, 4 September. Meaning you'll need to own shares at market close today to have rights to that payout.

Eligible investors can then expect to see that passive income hit their bank account on 26 September.

Looking to the year ahead, the ASX 200 healthcare share forecasts growth in its net profit after tax from continuing operations in FY 2025. Though margin recovery is expected to be slow, impacted by ongoing inflationary pressures and investments in business enablement programs.

The Ramsay share price is down 24% year to date.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Healthcare Shares

Is this beaten-down ASX healthcare share a bargain buy now?

One expert has given their view on this stock.

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Healthcare Shares

3 ASX healthcare shares going gangbusters on Thursday

Investors are sending these ASX healthcare stocks soaring today. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Is it time to cash in on Sigma shares?

Shares have extended after the Chemist Warehouse merger.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Healthcare Shares

Buy this ASX 200 share that is swimming in cash

Bell Potter sees potentially big returns on offer from this cashed-up stock.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Are CSL shares a buy after the biotech's FY25 forecasts?

Brokers continue to weigh in.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?

These two stocks are both leaders in the industry.

Read more »

A young man goes over his finances and investment portfolio at home.
Healthcare Shares

Down 20%, is the NIB share price undervalued?

Here's what Goldman Sachs is saying about this blue chip stock.

Read more »

four excited doctors with their hands in the air
Healthcare Shares

Sigma Healthcare shares rocket 39% on Chemist Warehouse merger approval

The ACCC doesn't believe the company's merger with Chemist Warehouse will lessen competition.

Read more »